Re: Novavax (NVAX): Un Nuevo Comienzo
Novavax Reaches Significant Enrollment Milestone in the Prepare(TM) Phase 3 Trial of its RSV F Vaccine
- Prepare trial is assessing the efficacy of Novavax’ RSV F Vaccine for infants via maternal immunization
- Enrollment of ~4,600 participants enables initiation of interim efficacy analysis
- Topline efficacy data from analysis expected in the first quarter of 2019
Comorrrr? No interim data en 2019 sino ya los topline data????? jodo, no??? :))))))))))) surprise surprise
edito: espera, espera, creo que lei demasiado rapido la press release